Loading...

LFWD LIFEWARD LTD Company Mergers 8-K Filing

LFWR

LFWD

LIFEWARD LTD

(LFWD)

2026 8-K

Financial Results Update

Executive Departure

Compliance Restored

Acquisition Completed

Compliance Notice Received

Financial Results Announcement

Shareholder Meeting Results

Compliance Regained

Share Consolidation

Board Departure

Asset Acquisition

New Loan Agreement

Compliance Update

Board Revisions

Share Purchase Agreement

Shareholder Meeting Results

Preliminary Results

Quarterly Results

CFO Appointment

Equity Offerings

Financial Statements

Financial Update

Financial Results

Meeting Cancellation

Exhibit Correction

Q3 Financial Results

Board Expansion

Q2 Financial Results

Management Change

Appointment of Director

Compliance regained with Na...

Investor Presentation

Earnings Reports

Extension for Bid Price Com...

Amendment to Form 8-K/A

Investor Presentation

Departure of Directors and ...

Completion of Acquisition

Merger of Equals

Departure of Directors

Investor Presentation

Compliance Extension Granted

FDA Clearance for ReWalk Ex...

Earnings Reports

External Links:

On January 12, 2026, Lifeward Ltd. signed a Share Purchase Agreement to acquire Oratech, a subsidiary of Oramed Pharmaceuticals, involving issuing shares and warrants amounting to 49.99% of its equity. This significant transaction includes a $20 million convertible notes arrangement and revenue sharing based on product sales.

AI Assistant

LIFEWARD LTD

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.